Cresco Labs (OTC: CRLBF) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.01) by 200 percent. This is a 25 percent increase over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $151.000 million which beat the analyst consensus estimate of $148.581 million by 1.63 percent. This is a 8.90 percent decrease over sales of $165.757 million the same period last year.